Abattis Bioceuticals Corp. (ATTBF)

[GreenBrickRoad]

This company used to have a valuation of 200-300M in 2014. Obviously, that was way too generous as the pps sank from the $2's to a few cents in 2 years and some of their partly owned operations and subsidiaries never panned out.

The ultimate strategy behind this company was to diversify into all aspects of marijuana, growing, drying, extracting, refining, and selling. In theory, at least a couple of their many arms would start producing. Nothing came of any of it.

What's a fair valuation today? Hard to play that game. Now that Northern Vine has the testing license and Health Canada has indicated this will be an up and coming demanded service, and that Abattis announced plans to start selling some of the products in its pipeline through GDP, a little imagination could lead us to believe that its current valuation below 20M is low.